Chronic Rhinosinusitis Without Nasal Polyps
14
5
7
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
7.1%
1 terminated out of 14 trials
75.0%
-11.5% vs benchmark
29%
4 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (14)
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps
Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Pistacia Lentiscus Oil Nasal Drops for Preventing Recurrence of Chronic Rhinosinusitis
A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis (CRS).
Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP
3D Printing to Improve Nasal Irrigation Outcome
Dupilumab in CRSsNP
Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment
Adherence in Global Airways - Steroid Intake and Effects on Chronic Rhinosinosinutis
Adherence in Global Airways
Safety and Efficacy of SDX-3101 for the Treatment of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)